Wood LJ, Mukherjee M, Tesfaye A, Sumter Felder T, and Resar LMS. (2007) HMGA2 is required for transformation in human lung cancer. (In preparation).
Felder Sumter T, Dhara S, Bhattacharya R, Turkson J, Jove R, and Resar LMS. (2007) STAT3: An HMGA1a target gene up-regulated in leukemogenesis and a possible therapeutic target. (Submitted)
Gray T, Morrey EL, Gangadharan B, Sumter T.F., Spychala J, Archer DR, Spencer HT. (2006) “Enforced expression of cytosolic 5'-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection,” Cancer Chemother Pharmacol. 2006 Jul; 58(1):117-28
(2005) “Navigating the First Year of
Felder, T. (2004)
“Nothing is Impossible to a Willing Heart: Experiences of Minorities in
Science” Science’s Nextwave.
Hommura, F., Katabumi, M., Leaner, V.D., Donninger, H., Sumter T.F., Resar, L.M., Birrer, M.J. (2004) HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells. Mol. Cancer Res. 2:305-314.
Xu, Y., Felder-Sumter, T. , Bhattacharya, R., Tesfaye, A., Fuchs, E.J., Wood L.J., Huso, D., Resar, L.M.S. (2004) The HMG-I Oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res. 64:3371-3375.
M.C. Nivens, T. Felder, A. Galloway*, M. Pena, J. Pouliot, and H.T. Spencer. (2003) "Engineered resistance to camptothecin and antifolates by retroviral co-expression of tyrosyl DNA Phosphodiesterase-1 and thymidylate synthase” Cancer Chemotherapy and Pharmacology. e-published ahead of print
T. Felder, R. B. Dunlap, D. Dix, and T. Spencer. (2002) “Differences in natural ligand and fluoropyrimidine binding to human thymidylate synthase identified by transient-state spectroscopic and continuous variation methods. Biochim Biophys Acta. 1597:149-56.
Stephens, C.E., Felder, T.M., Sowell, J.W., Adrei, G., Balz, J., Snoeck, R., De Clerq, E. (2001) “Synthesis and Antiviral Evaluation of 2-Amino- and 2-Carboxamido-3-arylsulfonylthiophenes and Related Compounds as a New Class of Diarylsulfones. Bioorg. Med. Chem. 9: 1123-1132.